INTECH INVESTMENT MANAGEMENT LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1086318 WEST PALM BEACH, FL

Position in HALO

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$10,525,900

-$2,747,409 QoQ

Shares Held

162,864

-17.4% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 19% Shared 0% None 81%

Healthcare · as of Mar 31, 2026

INTECH INVESTMENT MANAGEMENT LLC holds $193,060,008 across 175 Biotechnology names. HALO ranks #4 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	68,009	$22,502,137
2	EXEL	Exelixis, Inc.	401,748	$17,230,971
3	INCY	Incyte Corp	136,704	$12,866,580
4	HALO	Halozyme Therapeutics, Inc. This page	162,864	$10,525,900
5	VRTX	Vertex Pharmaceuticals Inc / Ma	19,713	$8,802,642
6	REGN	Regeneron Pharmaceuticals, Inc.	9,319	$7,200,231
7	JAZZ	Jazz Pharmaceuticals plc	34,379	$6,499,349
8	PTCT	Ptc Therapeutics, Inc.	55,949	$3,811,805

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,525,900	162,864	-17.4%	Shares	Sole	2026-05-08
2025-12-31	$13,273,309	197,226	+32.7%	Shares	Sole	2026-02-10
2025-09-30	$10,903,237	148,667	+46.0%	Shares	Sole	2025-11-12
2025-06-30	$5,296,520	101,817	-33.5%	Shares	Sole	2025-08-08
2025-03-31	$9,775,628	153,199	+9.9%	Shares	Sole	2025-05-20
2024-12-31	$6,665,192	139,410	+147.6%	Shares	Sole	2025-02-11
2024-09-30	$3,222,898	56,305	+147.4%	Shares	Sole	2024-11-08
2024-06-30	$1,191,870	22,763	—	Shares	Sole	2024-08-12
No filing history on record for this holder in this stock.